Copyright Reports & Markets. All rights reserved.

Global Alzheimer's Disease Diagnostic Market Size, Status and Forecast 2021-2027

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Genetic testing
    • 1.2.3 Neurological exam
    • 1.2.4 Mini-mental state exam (MMSE)
    • 1.2.5 Brain imaging
    • 1.2.6 Other
  • 1.3 Market by Application
    • 1.3.1 Global Alzheimer's Disease Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Clinics
    • 1.3.3 Hospitals
    • 1.3.4 Diagnostic Centers
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Alzheimer's Disease Diagnostic Market Perspective (2016-2027)
  • 2.2 Alzheimer's Disease Diagnostic Growth Trends by Regions
    • 2.2.1 Alzheimer's Disease Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Alzheimer's Disease Diagnostic Historic Market Share by Regions (2016-2021)
    • 2.2.3 Alzheimer's Disease Diagnostic Forecasted Market Size by Regions (2022-2027)
  • 2.3 Alzheimer's Disease Diagnostic Industry Dynamic
    • 2.3.1 Alzheimer's Disease Diagnostic Market Trends
    • 2.3.2 Alzheimer's Disease Diagnostic Market Drivers
    • 2.3.3 Alzheimer's Disease Diagnostic Market Challenges
    • 2.3.4 Alzheimer's Disease Diagnostic Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue
    • 3.1.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue (2016-2021)
    • 3.1.2 Global Alzheimer's Disease Diagnostic Revenue Market Share by Players (2016-2021)
  • 3.2 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Alzheimer's Disease Diagnostic Revenue
  • 3.4 Global Alzheimer's Disease Diagnostic Market Concentration Ratio
    • 3.4.1 Global Alzheimer's Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnostic Revenue in 2020
  • 3.5 Alzheimer's Disease Diagnostic Key Players Head office and Area Served
  • 3.6 Key Players Alzheimer's Disease Diagnostic Product Solution and Service
  • 3.7 Date of Enter into Alzheimer's Disease Diagnostic Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer's Disease Diagnostic Breakdown Data by Type

  • 4.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Type (2016-2021)
  • 4.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2022-2027)

5 Alzheimer's Disease Diagnostic Breakdown Data by Application

  • 5.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Application (2016-2021)
  • 5.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Alzheimer's Disease Diagnostic Market Size (2016-2027)
  • 6.2 North America Alzheimer's Disease Diagnostic Market Size by Type
    • 6.2.1 North America Alzheimer's Disease Diagnostic Market Size by Type (2016-2021)
    • 6.2.2 North America Alzheimer's Disease Diagnostic Market Size by Type (2022-2027)
    • 6.2.3 North America Alzheimer's Disease Diagnostic Market Size by Type (2016-2027)
  • 6.3 North America Alzheimer's Disease Diagnostic Market Size by Application
    • 6.3.1 North America Alzheimer's Disease Diagnostic Market Size by Application (2016-2021)
    • 6.3.2 North America Alzheimer's Disease Diagnostic Market Size by Application (2022-2027)
    • 6.3.3 North America Alzheimer's Disease Diagnostic Market Size by Application (2016-2027)
  • 6.4 North America Alzheimer's Disease Diagnostic Market Size by Country
    • 6.4.1 North America Alzheimer's Disease Diagnostic Market Size by Country (2016-2021)
    • 6.4.2 North America Alzheimer's Disease Diagnostic Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Alzheimer's Disease Diagnostic Market Size (2016-2027)
  • 7.2 Europe Alzheimer's Disease Diagnostic Market Size by Type
    • 7.2.1 Europe Alzheimer's Disease Diagnostic Market Size by Type (2016-2021)
    • 7.2.2 Europe Alzheimer's Disease Diagnostic Market Size by Type (2022-2027)
    • 7.2.3 Europe Alzheimer's Disease Diagnostic Market Size by Type (2016-2027)
  • 7.3 Europe Alzheimer's Disease Diagnostic Market Size by Application
    • 7.3.1 Europe Alzheimer's Disease Diagnostic Market Size by Application (2016-2021)
    • 7.3.2 Europe Alzheimer's Disease Diagnostic Market Size by Application (2022-2027)
    • 7.3.3 Europe Alzheimer's Disease Diagnostic Market Size by Application (2016-2027)
  • 7.4 Europe Alzheimer's Disease Diagnostic Market Size by Country
    • 7.4.1 Europe Alzheimer's Disease Diagnostic Market Size by Country (2016-2021)
    • 7.4.2 Europe Alzheimer's Disease Diagnostic Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Alzheimer's Disease Diagnostic Market Size (2016-2027)
  • 8.2 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Type
    • 8.2.1 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Application
    • 8.3.1 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region
    • 8.4.1 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Alzheimer's Disease Diagnostic Market Size (2016-2027)
  • 9.2 Latin America Alzheimer's Disease Diagnostic Market Size by Type
    • 9.2.1 Latin America Alzheimer's Disease Diagnostic Market Size by Type (2016-2021)
    • 9.2.2 Latin America Alzheimer's Disease Diagnostic Market Size by Type (2022-2027)
    • 9.2.3 Latin America Alzheimer's Disease Diagnostic Market Size by Type (2016-2027)
  • 9.3 Latin America Alzheimer's Disease Diagnostic Market Size by Application
    • 9.3.1 Latin America Alzheimer's Disease Diagnostic Market Size by Application (2016-2021)
    • 9.3.2 Latin America Alzheimer's Disease Diagnostic Market Size by Application (2022-2027)
    • 9.3.3 Latin America Alzheimer's Disease Diagnostic Market Size by Application (2016-2027)
  • 9.4 Latin America Alzheimer's Disease Diagnostic Market Size by Country
    • 9.4.1 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2016-2021)
    • 9.4.2 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Alzheimer's Disease Diagnostic Market Size (2016-2027)
  • 10.2 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Type
    • 10.2.1 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Application
    • 10.3.1 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country
    • 10.4.1 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Eli Lilly
    • 11.1.1 Eli Lilly Company Details
    • 11.1.2 Eli Lilly Business Overview
    • 11.1.3 Eli Lilly Alzheimer's Disease Diagnostic Introduction
    • 11.1.4 Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2016-2021)
    • 11.1.5 Eli Lilly Recent Development
  • 11.2 TauRx
    • 11.2.1 TauRx Company Details
    • 11.2.2 TauRx Business Overview
    • 11.2.3 TauRx Alzheimer's Disease Diagnostic Introduction
    • 11.2.4 TauRx Revenue in Alzheimer's Disease Diagnostic Business (2016-2021)
    • 11.2.5 TauRx Recent Development
  • 11.3 Alector
    • 11.3.1 Alector Company Details
    • 11.3.2 Alector Business Overview
    • 11.3.3 Alector Alzheimer's Disease Diagnostic Introduction
    • 11.3.4 Alector Revenue in Alzheimer's Disease Diagnostic Business (2016-2021)
    • 11.3.5 Alector Recent Development
  • 11.4 Accera
    • 11.4.1 Accera Company Details
    • 11.4.2 Accera Business Overview
    • 11.4.3 Accera Alzheimer's Disease Diagnostic Introduction
    • 11.4.4 Accera Revenue in Alzheimer's Disease Diagnostic Business (2016-2021)
    • 11.4.5 Accera Recent Development
  • 11.5 Treventis
    • 11.5.1 Treventis Company Details
    • 11.5.2 Treventis Business Overview
    • 11.5.3 Treventis Alzheimer's Disease Diagnostic Introduction
    • 11.5.4 Treventis Revenue in Alzheimer's Disease Diagnostic Business (2016-2021)
    • 11.5.5 Treventis Recent Development
  • 11.6 Neuro-Bio
    • 11.6.1 Neuro-Bio Company Details
    • 11.6.2 Neuro-Bio Business Overview
    • 11.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Introduction
    • 11.6.4 Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2016-2021)
    • 11.6.5 Neuro-Bio Recent Development
  • 11.7 Cognition Therapeutics
    • 11.7.1 Cognition Therapeutics Company Details
    • 11.7.2 Cognition Therapeutics Business Overview
    • 11.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Introduction
    • 11.7.4 Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2016-2021)
    • 11.7.5 Cognition Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Alzheimer's Disease Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Genetic testing
    Neurological exam
    Mini-mental state exam (MMSE)
    Brain imaging
    Other

    Segment by Application
    Clinics
    Hospitals
    Diagnostic Centers
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Eli Lilly
    TauRx
    Alector
    Accera
    Treventis
    Neuro-Bio
    Cognition Therapeutics
    Accera

    Buy now